for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Company News

Maravai LifeSciences shares rise 18% in debut

Nov 20 (Reuters) - Shares of Maravai LifeSciences, which provides a capping reagent to Pfizer and BioNTech for their COVID-19 vaccine, rose 18.3% in their debut on Friday, after the company raised $1.62 billion in its upsized initial public offering. (Reporting by Noor Zainab Hussain in Bengaluru; Editing by Maju Samuel)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up